Sort
10,766 grants matching “checkpoint inhibitor”
DNA damage signaling in oxygen toxicity in lung cells
$269,283Kumuda C Das · Univ Of Arkansas For Med Scis · R01 · FY2007 · HL
Targeting cellular senescense in pancreatic cancer
$269,280Haiyong Han · Translational Genomics Research Inst · R21 · FY2025 · CA
An Exploratory Study of UCN-01 and Irinotecan in Advanced Triple Negative Breast
$269,233Paula M Fracasso · University Of Virginia · R21 · FY2008 · CA
Project 1:Therapeutically improving HNSCC antigenicity through epigenetic reprogramming
$268,727Sara Isabel Pai · Yale University · P01 · FY2023 · CA
Project 1
$268,645Kunle O Odunsi · Roswell Park Cancer Institute Corp · P50 · FY2023 · CA
Immune Checkpoint Blockade Targeting the Novel PSGL-1/VISTA Axis for Pancreatic Cancer
$268,345Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2025 · CA
Aurora-A/BTAK/STK15 Oncoprotein in Mitotic Spindle Assembly and Checkpoint Respon
$268,335Subrata Sen · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Transcriptional silencing by the BCL6 oncoprotein
$268,277Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · CA
Aurora-A/BTAK/STK15 Oncoprotein in Mitotic Spindle Assembly and Checkpoint Respon
$268,236Subrata Sen · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Project 3
$268,195Michelle Krogsgaard · New York University School Of Medicine · P50 · FY2020 · CA
In vivo testing of an agonistic anti-GITR mAb that induces cell surface clustering to augment signal transduction and a 2nd Gen bispecific anti-GITR/PD1 Ab derivative for improved anti-tumor activity
$268,059Wayne A. Marasco · Dana-Farber Cancer Inst · R21 · FY2024 · CA
Development of microfluidic enabled CRISPR-Cas9 functional genetic screening technologies for target discovery in cancer immunotherapy
$268,031Shana O Kelley · Northwestern University · R01 · FY2022 · CA
Apoptosis in Postmitotic Cells: Increased Regulation and Novel Checkpoints
$267,818Mohanish Deshmukh · Univ Of North Carolina Chapel Hill · R01 · FY2008 · GM
Apoptosis in Postmitotic Cells: Increased Regulation and Novel Checkpoints
$267,818Mohanish Deshmukh · Univ Of North Carolina Chapel Hill · R01 · FY2007 · GM
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
$267,770Evanthia Theodosiou Roussos Torres · University Of Southern California · P20 · FY2025 · CA
Imaging and theranostics to detect and promote an immune reactive tumor microenvironment
$267,481Zaver M Bhujwalla · Ut Southwestern Medical Center · P41 · FY2024 · EB
Trancriptional silencing by the Bcl-6 Oncoprotein
$267,478Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R56 · FY2009 · CA
Circulating cell free tumor DNA (ctDNA) in patients with immune checkpoint inhibitor associated inflammatory arthritis (ICI-IA): developing a biomarker to assess immunosuppressive drug safety
$267,423Anne R Bass · Hospital For Special Surgery · R01 · FY2025 · AR
Project 2: Discovery and validation of novel molecular and immune predictors of colorectal cancer and mortality and response to treatment across patient populations groups
$267,212Christopher I Li · Fred Hutchinson Cancer Center · P50 · FY2025 · CA
P3: Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint BlockadeýSUBAWARD
$266,898David Sung-Wen Yu · Cleveland Clinic Lerner Com-Cwru · U54 · FY2023 · CA
Targeted immunotherapy for relapsed/refractory Hodgkin lymphoma
$266,884Robert Wi Chen · Beckman Research Institute/City Of Hope · P50 · FY2020 · CA
BRIT 1: Roles in Immortalization, Checkpoints and Cancer
$266,625University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Mechanistic study on synergistic photo-immunological effects of laser immunotherapy for metastatic cancers
$266,624Wei R. Chen · University Of Central Oklahoma · R01 · FY2019 · CA
Immunophenotypic biomarkers to predict response and optimize immunotherapy-based combinations in breast cancer
$266,518Cesar Augusto Santa-Maria · Johns Hopkins University · K08 · FY2022 · CA
Immunophenotypic biomarkers to predict response and optimize immunotherapy-based combinations in breast cancer
$266,518Cesar Augusto Santa-Maria · Johns Hopkins University · K08 · FY2023 · CA